← Leaderboards
Irving Nachamkin
University Of Pennsylvania
$497,593
Attributed
$497,593
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249.6K · FY2005–11$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$497,593 · 4
By mechanism
R21$437,600 · 1
R13$59,993 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ricardo Castillo Neyra$3,448,323
- Bruce J Shenker$14,692,911
- Rohan Palanki$178,372
- Joshua P Metlay$9,962,851
- Stephen Douglas Cole$649,353
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventPublic Health Medicine (Field)OrganismPathogenesisInfectionDiarrheaResearch PersonnelGastrointestinal InfectionPreventionAnimal ModelBaseImmune ResponseAntimicrobial DrugEnvironmentAntigensAntibody TherapyAntibody AffinityAnimal EcologyAlloantigenCampylobacterAntibiotic TherapyAutoantibodiesAntibodiesAuthority
Grant awards (5)
Development of a novel antibody therapy for clostridium difficile infection$237,600
R21 · FY2011 · AI · contact PI
16th international conference on Campylobacter, Helicobacter and related organism$12,000
R13 · FY2011 · AI · contact PI
Development of a novel antibody therapy for clostridium difficile infection$200,000
R21 · FY2010 · AI · contact PI
14th International CHRO Workshop$20,000
R13 · FY2007 · AI · contact PI
13th International Campylobacter/Helicobacter workshop$27,993
R13 · FY2005 · DK